Skip to main content
. 2019 Jan 7;23(3):2256–2262. doi: 10.1111/jcmm.14105

Figure 1.

Figure 1

Treatment with NTN‐1, UNC5B siRNA or BADGE has no effects on mortality rates and SAH grade in SAH models. A, Mortality rates in the SAH group (8%), the SAH + NTN‐1 group rate (16.2%), the SAH + NTN‐1+ UNC5B siRNA group rate (19.8%), the SAH + NTN‐1+ BADGE group (16.2%), and the SAH + NTN‐1+ scramble siRNA group (21.6%). B, The SAH grade scores in the SAH group, the SAH + NTN‐1 group, the SAH + NTN‐1+ UNC5B siRNA group, the SAH + NTN‐1+ BADGE group, and the SAH + NTN‐1+ scramble siRNA group, which showed no significant differences (one‐way ANOVA analysis)